irinotecan
Selected indexed studies
- Liposomal irinotecan (Onivyde): Exemplifying the benefits of nanotherapeutic drugs. (Cancer Sci, 2022) [PMID:35445479]
- Irinotecan-Still an Important Player in Cancer Chemotherapy: A Comprehensive Overview. (Int J Mol Sci, 2020) [PMID:32664667]
- Individualization of Irinotecan Treatment: A Review of Pharmacokinetics, Pharmacodynamics, and Pharmacogenetics. (Clin Pharmacokinet, 2018) [PMID:29520731]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Liposomal irinotecan (Onivyde): Exemplifying the benefits of nanotherapeutic drugs. (2022) pubmed
- Irinotecan-Still an Important Player in Cancer Chemotherapy: A Comprehensive Overview. (2020) pubmed
- Individualization of Irinotecan Treatment: A Review of Pharmacokinetics, Pharmacodynamics, and Pharmacogenetics. (2018) pubmed
- Irinotecan dose schedule for the treatment of Ewing sarcoma. (2023) pubmed
- Irinotecan pharmacogenomics. (2010) pubmed
- Irinotecan toxicity. (2007) pubmed
- Liposomal Irinotecan: A Review as First-Line Therapy in Metastatic Pancreatic Adenocarcinoma. (2025) pubmed
- [Irinotecan pharmacokinetics]. (1998) pubmed
- Mechanisms and emerging strategies for irinotecan-induced diarrhea. (2024) pubmed
- Pharmacology of irinotecan. (1998) pubmed